Table 3: Efficacy of the survey approach to distinguishing entheseal reaction disease specificity.

Status	Age	San Francisco	Mases	Berlin	SPARCC‡	Impact	Leed	Major	Mander
Rheumatoid	57.18	1.53	0.24	1.88	4.94	1.35	1.24	2.88	7.41
Spondyloarthropathy	58.12	1.53	0.24	1.88	4.82	1.38	1.24	3.59	11.35
CPPD	59.38	1.57	0.48	1.96	5.43	1.29	1.48	3.57	13.00
DISH	64.25	1.50	0.13	1.75	4.19	1.38	1.25	3.06	10.31
Healthy^*	61.06	1.50	0.13	1.75	3.63	1.38	1.25	2.50	5.75
ANOVA	NS†	NS	NS	NS	NS	NS	NS	NS	P = 0.068
RA+healthy vs. others									P = 0.038

^*Absence of disorders in which enthesial reaction is suspected, including hypertrophic osteoarthropathy, renal disease, syphilis; †Not significant; ‡Spondyloarthritis Research Consortium of Canada Enthesitis Index.